Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.
about
Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccineDiscerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacyMonoclonal antibodies to conformational epitopes of the surface glycoprotein of caprine arthritis-encephalitis virus: potential application to competitive-inhibition enzyme-linked immunosorbent assay for detecting antibodies in goat seraEpitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.Biological characterization of Rev variation in equine infectious anemia virusPriming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV.Equine infectious anemia virus is found in tissue macrophages during subclinical infectionCommon themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equidsEquine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challengeDevelopment and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway.Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from diseaseAnalysis of the antibody response to an immunodominant epitope of the envelope glycoprotein of a lentivirus and its diagnostic potential.Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.Envelope determinants of equine lentiviral vaccine protection.Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins.Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.Cell-Intrinsic gp130 Signaling on CD4+ T Cells Shapes Long-Lasting Antiviral ImmunityCTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteinsEarly detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horsesDynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.Envelope variation as a primary determinant of lentiviral vaccine efficacy.Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection.Western blot assay using recombinant p26 antigen for detection of equine infectious anemia virus-specific antibodiesDevelopment of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4⁺ T cell responses and viral control during chronic infection.A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccineNovel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony
P2860
Q21131325-A1C7365E-1E93-483E-91BB-059BE336FFA4Q24556682-06FA38CD-D624-4F3D-8A35-610C05990532Q28345448-2175583F-4A4C-4D7B-A4DD-28B9BDB9BA48Q33349793-3487CC70-4EDD-40F2-918C-3108C5C6CC6EQ33643247-42400944-1D08-4144-842F-664BD343C892Q33782904-D22BE37F-C14F-4CBD-8B41-A8CACBE8992BQ33783635-5D9206B7-2ADD-468E-A1D6-717AC5993BBDQ33783820-50B39617-4CE1-4696-A5E9-691D44E56A8FQ33784692-391920BA-BAA4-447B-B596-4B0E00A287BDQ33785383-94B49BB5-486B-4BAE-8F33-19258BC585BFQ33801103-5B05169B-0883-4236-9DA8-AB6062440E16Q33840365-6F678874-1EAC-4DF9-B7A4-02B71F97040AQ33910741-42980CF2-FB2F-4E5C-AEE6-670EDCA53ADDQ34069791-E0836413-4F5B-4A01-850B-D70DDC90FB4AQ34133986-6BE88D09-8A43-40C2-AD85-F3437B7D6D7DQ34142939-B3C76501-CD37-4C0C-842C-696CDA3F43ABQ34257060-4F37042F-E7CA-4477-9041-FD429CED972AQ34349343-0683AFA1-11B5-4212-9D54-806911A5F384Q34380211-FC2F57CB-9680-4FF3-A733-53A1B6AA88C6Q34431922-F3CFC7D7-59BE-4C1E-9392-28989ECDF7FBQ34466693-E5348646-3F38-4382-96A7-6C74DB6D05B6Q34778836-28154B52-B7D5-496C-9139-DF5C83088AEFQ35077483-259FA696-59EE-454F-BFA4-84088D516609Q35148952-13D4F4AA-3176-4667-A50A-7C0DB3494FA8Q35613328-18DEC059-8775-49E8-BD78-2ECF541DBB95Q35758001-87EF848E-BBDE-4CFD-BB64-F93ED563900EQ35864505-D9663ECF-BA8F-4321-B1C5-ECC94422F936Q35928180-315E01ED-E737-409B-BD45-F7BB6AB622FEQ35929492-9FFBAEF4-C19A-4029-B417-2332DA27E912Q35929560-B05B4A4E-76C5-4A2B-986E-B6A44AB14546Q35948180-EB8606AF-90D4-4284-97CF-02733C3E147EQ35992786-6F1186F1-57D6-4528-A97D-A9C5B9902C2DQ36002639-0F5981D4-2872-4A5E-BBFD-32953B3E2E2CQ36029988-B55626A2-476B-4BED-8637-268A54EC93CEQ36073682-AFF081A1-8D80-457C-ABF7-BBB648A3BA1BQ36314078-041311CD-1F66-4726-8DAB-AE24032908C3Q36328526-99F7C535-8F43-4C19-A033-D711A2BD14F6Q36429708-039BCF65-649B-459D-9DEB-755CACCFD5EBQ36456552-4C6239B7-452E-4231-A429-BE520B011115Q36549092-93F79CD7-58D2-4CD2-B506-15504B8ABDBB
P2860
Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Maturation of the cellular and ...... a complex and lengthy process.
@ast
Maturation of the cellular and ...... a complex and lengthy process.
@en
type
label
Maturation of the cellular and ...... a complex and lengthy process.
@ast
Maturation of the cellular and ...... a complex and lengthy process.
@en
prefLabel
Maturation of the cellular and ...... a complex and lengthy process.
@ast
Maturation of the cellular and ...... a complex and lengthy process.
@en
P2093
P2860
P1433
P1476
Maturation of the cellular and ...... a complex and lengthy process
@en
P2093
D L Lichtenstein
R C Montelaro
S A Hammond
P2860
P304
P407
P577
1997-05-01T00:00:00Z